Market Activities

From March 21 to 24, 2025, the 40th European Association of Urology Congress (EAU25) will be held in the capital of Spain, featuring Europe’s largest urology event. MacroLux showcased its high-performance urology products in Madrid.

MacroLux Medical Technology Co., Ltd. announced the successful close of its Series B+ financing round led by B Capital. The funding will support MacroLux Medical’s continued global expansion and accelerate growth in the disposable endoscope market.

The 53rd Annual Meeting of the American Association of Gynecologic Laparoscopists (AAGL 2024) was held from November 17 to 19 in New Orleans, USA.

From November 11 to 14, 2024, MacroLux Medical participated in Medica 2024 at the Düsseldorf Exhibition Center in Germany. This event is a significant occasion in the global medical technology field, attracting top medical technology and innovative achievements from around the world.

We are very pleased to announce that our company (hereinafter referred to as MacroLux Medical) recently announced the completion of over 14 million dollars in Series B financing. The round was led by Yuanbio Venture Capital, with continued support from existing shareholders Legend Capital and Dalton Venture, and Haoyue Capital acted as the exclusive financial advisor.

Congratulations to MacroLux Medical on obtaining CE-MDR certification for their three cutting-edge disposable digital endoscopes: LoopView® Single-Use Digital Flexible Bronchoscope, BubbleView® Single-Use Digital Flexible Cystoscope, and SeleneView® Single-Use Digital Hysteroscope.

From August 12th to 16th, 2024, the 41st World Congress of Endourology and Uro-Technology (WCET) was held in Seoul, South Korea. MacroLux Medical showcased its superior urological products during the event in Seoul.

We are thrilled to announce that our disposable hysteroscope SeleneView® has obtained the 510(k) clearance from the U.S. Food and Drug Administration (FDA), marking a momentous milestone for us.